169169 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Cells of the immune system
Devices and methods related to airway inflammation
#302In vitro method for determining the stability of compositions comprising soluble Fc gamma receptor(s)
#303Methods of detecting prenatal or pregnancy-related diseases or conditions
#304Application of mesenchymal stem cells in prophylaxis or treatment of stress response-induced weakened immunity
#305Cell model for neovascular diseases using EBV-infected human corneal epithelial cells
#306Development Of Natural Killer Cells And Functional Natural Killer Cell Lines
#307CGRP RECEPTOR AGONIST FOR HIV TREATMENT OR PREVENTION
#308Intercellular labeling of ligand-receptor interactions
#309Glatiramer acetate human monocytic cell line-based potency assay
#310Compositions for and methods of identifying antigens
#311Antigen screening system
#312Allogeneic autophagosome-enriched composition for the treatment of disease
#313Cytokine derived treatment with reduced vascular leak syndrome
#314In vitro method for assessing cytokine storm responses
#315Anti-lymphocyte autoantibodies as diagnostic biomarkers
#316Immunovir and Components, Immunovir A, B, C, D Utility and Useful Processes
#317Process for assessing risk of substance administration
#318Method for hematology analysis
#319Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
#320Skin model
#321Dendritic cell response gene expression, compositions of matters and methods of use thereof
#322Cell mediated immune response assay
#323T cell receptors with MHC independent binding to GM-CSF receptor alpha chain
#324ANTI-MIF ANTIBODY CELL MIGRATION ASSAY
#325Agents that modulate immune cell activation and methods of use thereof
#326Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#327Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#328Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
#329Methods of treating and preventing infections and associated conditions
#330Immunomodulating compositions and uses therefor
#331Method for measuring ATR inhibition mediated increases in DNA damage
#332Peptides that block leukocyte recruitment and methods of use
#333Screening method, screening kit and analysis program
#334Human myeloid derived suppressor cell cancer markers
#335PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF
#336INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER
#337Filoviral Immunosuppressive Peptides
#338Micro-fluidic devices for assaying biological activity
#339Method for quantifying immune cells in tumoral tissues and its applications
#340COMPOSITIONS AND METHODS FOR TREATMENT
#341Methods for Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom, and Uses Thereof
#342Methods for identifying beta-glucan binding to immune cells
#343METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#344Anti-FcRn antibodies
#345Method for Identifying Agents Capable of Inducing Respiratory Sensitization and Array and Analytical Kits for Use in the Method
#346METHODS FOR DETERMINING THE EFFECTS OF COMPOUNDS ON JAK/STAT ACTIVITY
#347Method for production of eosinophil from pluripotent stem cell
#348Antibodies that specifically bind to TIM3
#349Identification and use of novopeptides for the treatment of cancer
#350GEOMETRICALLY ENGINEERED PARTICLES AND METHODS FOR MODULATING MACROPHAGE OR IMMUNE RESPONSES
#351Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#352METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#353MODULATION OF PEPTIDOME USING HISTONE DEACETYLASE INHIBITOR
#354In vitro modelling of haematopoietic stem cell medullary nests: a tool for studying the regulation of haematopoiesis, evaluating the nesting potential of a haematopoietic graft and testing the pharmacotoxicology of medicaments
#355High throughput sensitization detection devices and methods
#356Detection of human somatic cell reprogramming
#357Flow cytometry assay methods
#358Human mast cell lines, preparation and uses
#359Flow-through cell counting assay
#360Indirect antigen-specific T cell recognition assay
#361Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#362Methods for determining drug efficacy using cereblon-associated proteins
#363Compositions and methods for treatment
#364METHODS FOR DIAGNOSIS PROGNOSIS AND METHODS OF TREATMENT
#365Induced intercellular communication
#366Method for measuring ATR inhibition mediated increases in DNA damage
#367METHOD FOR MONITORING VACCINE RESPONSE USING SINGLE CELL NETWORK PROFILING
#368Allogeneic autophagosome-enriched composition for the treatment of disease
#369Methods for detecting contaminants in solutions containing glucose polymers
#370Leukocyte activation and methods of use thereof
#371Tissue targeted antigenic activation of the immune response to treat cancers
#372Methods for determining personalized treatment compositions for prostate cancer and breast cancer
#373Tissue targeted antigenic activation of the immune response to treat cancers
#374Small molecules for endothelial cell activation
#375Pan-kinase activation and evaluation of signaling pathways
#376Diagnostic assay
#377Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#378Analytical Methods and Arrays for Use in the Same
#379Dendritic cell marker and uses thereof
#380Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events
#381Function homology screening
#382Method and compositions for the identification of agents that have a potential effect against chronic inflammatory diseases
#383Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
#384Anti-CD80 antibody
#385METHOD TO INHIBIT RECRUITMENT OF MONOCYTES AND MACROPHAGES BY AN ICAM-3 INHIBITOR
#386Method for target and drug validation in inflammatory and/or cardiovascular diseases
#387GLYCOSAMINOGLYCAN-ANTAGONISING MCP-1 MUTANTS AND METHODS OF USING SAME
#388Microfluidic assay in idealized microvascular network for characterization of leukocyte adhesion cascade
#389Antigen screening system
#390Method of identifying risk for thyroid disorder
#391Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease
#392DENDRITIC CELL IMMUNORECEPTOR AGONIST
#393ILCS BASED PATTERN RECOGNITION OF SEPSIS
#394SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS
#395Genetically modified human natural killer cell lines
#396Methods for Diagnosis, Prognosis and Methods of Treatment
#397Assay for measuring cell-mediated immunoresponsiveness
#398Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids
#399Antibodies that specifically bind to TIM3
#400FACS-based method for obtaining an antibody sequence
#401Methods of treating and preventing infections and associated conditions
#402Chaperonin 10 variants
#403IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#404PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#405Methods for diagnosis, prognosis and methods of treatment
#4063D ADCC NK FACS ASSAY
#407System and Method for Detecting and Quantifying Active T-cells or Natural Killer Cells
#408Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
#409Human myeloid derived suppressor cell cancer markers
#410Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
#411PEPTIDE MARKER FOR CANCER DIAGNOSIS, AND CANCER DIAGNOSIS METHOD USING SAME
#412METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS
#413HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE
#414Compositions and methods for treatment of eye disorders
#415DIAGNOSTIC METHOD FOR DETECTING CANCER BY MEASURING AMOUNT OF A CYTOKINE LIKE IL-6
#416Therapeutic Use of Farnesyltransferase Inhibitors and Methods of Monitoring the Efficacy Thereof
#417METHODS OF IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
#418Method of treatment and agents useful for same
#419METHOD FOR INFORMING A PURCHASER OF A TOPICAL SKIN CARE PREPARATION OF AN OXIDATIVE STRESS PROTECTIVE CAPACITY
#420Therapeutic use for ALPHA1 proteinase inhibitor in hematopoiesis
#421Methods and compositions for diagnostic assays for measuring cell mediated immune response
#422Compositions and methods for assessing cytotoxicity of single cells
#423PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION
#424Method of identifying patients not suitable for high-dose cyclophosphamide treatment
#425Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance
#426Use of lymphocytes to measure anthrax lethal toxin activity
#427METHOD FOR DETECTING TARGET CELL
#428Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy
#429Method for stimulating antigen-specific T cell responses using accelerated co-cultured dendritic cells
#430Molecular delivery with nanowires
#431Human mast cell line and uses thereof
#432IN VITRO ASSAY FOR IDENTIFICATION OF ALLERGENIC PROTEINS
#433Therapeutic Use Of Probiotics
#434METHOD FOR DIAGNOSING POMPE DISEASE
#435Anti-CD86 antibody
#436METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#437Use of myeloid cell biomarkers for the diagnosis of cancer
#438DENDRITIC CELL MODULATORY MOLECULE
#439Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#440METHODS FOR IDENTIFICATION
#441SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE
#442MIF antagonists
#443Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies
#444INTERFERON-ALFA SENSITIVITY BIOMARKERS
#445METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION
#446Method for diagnosing allergic reactions
#447Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof
#448Treatment of Fibrosis related disorders
#449Compositions and methods for suppressing fibrocytes
#450CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYER'S PATCHES AND USES THEREOF
#451Cells screening method
#452Modulation of splenocytes in cell therapy
#453ASSAYS TO PREDICT CARDIOTOXICITY
#454Device and method for detection of humidity-compromised urine test strips
#455Method for hematology analysis
#456Methods and Compositions for Risk Stratification
#457Methods for assaying responses to vaccines
#458Methods for diagnosis, prognosis and methods of treatment
#459Method for Monitoring Vaccine Response Using Single Cell Network Profiling
#460Detection of human somatic cell reprogramming
#461Compositions, methods and animal models for screening therapeutics for TH2-type disease
#462Methods of evaluating an immune response to an antigen
#463Methods and compositions for risk stratification
#464Methods and compositions for risk stratification
#465THERAPEUTIC USE OF FARNESYLTRANSFERASE INHIBITORS AND METHODS OF MONITORING THE EFFICACY THEREOF
#466Process for the measurement of the potency of glatiramer acetate
#467SCREEN FOR INHIBITORS OF HIV REPLICATION
#468Compositions and methods for treatment
#469Compositions and methods for treatment
#470Dendritic cell marker and uses thereof
#471Methods for diagnosis, prognosis and methods of treatment
#472PRODUCT AND METHOD FOR TREATMENT OF CONDITIONS ASSOCIATED WITH RECEPTOR-DESENSITIZATION
#473Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#474DRUG SAFETY TEST USING PENTRAXIN-3 (PTX-3)
#475Method for evaluation of function of phagocyte
#476Compositions for and methods of identifying antigens
#477Use of Urea-Adjuvated Polypeptides for Diagnosis, Prophylaxis and Therapy
#478Biomarker
#479Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof
#480Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids
#481Methods of suppressing microglial activation
#482Tissue targeted antigenic activation of the immune response to treat cancers
#483Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#484Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
#485Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#486HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3
#487ASSAY AND METHOD FOR THE ASSESSMENT OF RESPONDERS AND NON-RESPONDERS TO NK CELL MODULATION BY IMMUNOGLOBULIN THERAPY
#488METHOD OF EVALUATING HUMAN DENTRITIC CELLS AND HUMAN CELL IMMUNOTHERAPEUTIC AGENT
#489METHOD OF SELECTING HLA-DP4 LIGANDS AND THE APPLICATIONS THEREOF
#490Cytokine production-inducing antibody
#491ASSAY
#492METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#493SCREENING, THERAPY AND DIAGNOSIS
#494Compositions and methods for regulating NK cell activity
#495Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation
#496METHOD FOR ASSESSING POTENTIAL FOR TUMOR DEVELOPMENT AND METASTASIS
#497Method for efficient production of monocyte-derived multipotent cell (MOMC)
#498NOVEL BONE MASS INCREASING AGENT
#499PHARMACEUTICALS COMPOSITIONS COMPRISING ACTINOMYCETE GLYCEROL ACYL DERIVATIVES ANTIGENS, THEIR PROCESS OF EXTRACTION, AND THEIR USE AGAINST TUBERCULOSIS
#500Immunoglobulin constant region FC receptor binding agents
#501MODULATORS OF HYPERSENSITIVITY REACTIONS
#502Use of lymphocytes to measure anthrax lethal toxin activity
#503Allergy test based on flow cytometric analysis
#504Methods and compositions for risk stratification
#505Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
#506Treatment methods for fibrosis related disorders
#507MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#508Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#509Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#510METHOD AND COMPOSITION FOR TREATING IMMUNE COMPLEX ASSOCIATED DISORDERS
#511Glycosaminoglycan-antagonising MCP-1 mutants
#512In vitro germinal centers
#513Method for screening allergic disease-related molecule and cell lines to be used in the method
#514NOVEL THYMIC CELLULAR POPULATIONS AND USES THEREOF
#515METHODS FOR DIAGNOSING AND TREATING ALLERGIES
#516METHOD FOR INVESTIGATING THE RESPONSE TO A TREATMENT WITH A MONOCLONAL ANTIBODY
#517Thiophene derivatives for up-regulating HLA-DM activity
#518Method of Identifying Risk for Thyroid Disorder
#519Compositions and methods for treatment of eye disorders
#520COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#521Genetically modified human natural killer cell lines
#522Pan-Kinase Activation and Evaluation of Signaling Pathways
#523Genetically modified human natural killer cell lines
#524METHODS FOR PREDICTING PRODUCTION OF ACTIVATING SIGNALS BY CROSS-LINKED BINDING PROTEINS
#525Methods of predicting steroid responsiveness with Il-1RII
#526Cell culture system for determinging the sensitizing, allergenic and/or irritating effect of a substance
#527Degranulation inhibitor
#528Biomarkers for Multiple Sclerosis and Methods of Use Thereof
#529Identification of therapeutic agents for HIV infection
#530Antigen screening system
#531METHOD FOR DETECTION OF HUMAN PRECURSOR T CELL AND PRECURSOR B CELL
#532Assay and method
#533Method for restoring dendritic cell populations
#534Alpha1 proteinase inhibitor peptides methods and use
#535Fusion proteins and methods for modulation of immune response
#536Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
#537Method and substances for treating T-cell mediated autoimmune diseases
#538Diagnostic and therapeutic application of CTL and NK functionally selected cells
#539Gene Expression Profiles Associated with Asthma Exacerbation Attacks
#540Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
#541Receptor In Dendritic Cells
#542SELECTION OF PERSONALIZED CANCER THERAPY REGIMENS USING INTERFERING RNA FUNCTIONAL SCREENING
#543Methods of ameliorating inflammatory disease using an uPA antagonist
#544Diagnostic Methods and Genetic Markers for Alzheimer Disease
#545Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#546METHOD FOR CLASSIFYING AND COUNTING BASOPHILS
#547PERITONEAL DIALYSIS SOLUTION TEST METHOD
#548METHODS FOR MEASURING PRO-INFLAMMATORY SUBSTANCE LEVELS IN DIALYSIS SOLUTIONS AND DIALYSIS COMPONENTS
#549METHOD FOR ANALYSIS OF NKT CELL FUNCTION
#550In Vitro System for Assessing Immune Activity Using Pig Immune Cells
#551FUNCTIONAL IN VITRO IMMUNOASSAY
#552Receptor in Dendritic Cells
#553NOVEL USE OF AN INDICATOR CELL LINE FOR BIOASSAY
#554PEPTIDES AND PEPTIDOMIMETICS HAVING IMMUNE-MODULATING, ANTI-INFLAMMATORY, AND ANTI-VIRAL ACTIVITY
#555Compositions and methods for regulating NK cell activity
#556IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
#557Methods of suppressing microglial activation and systemic inflammatory responses
#558Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
#559Methods for Culturing Human Lung Mast Cells and Uses Thereof
#560METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#561Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
#562KINETIC BIOMARKER FOR QUANTIFICATION OF LYMPHOPROLIFERATION, CLONAL EXPANSION, RECRUITMENT AND TRAFFICKING IN LYMPHOID TISSUES AND OF THE IN VIVO ACTIONS OF ANTIGENS AND MODULATING THEREON
#563ANTIBODY AND METHOD FOR IDENTIFICATION OF DENDRITIC CELLS
#564Human papilloma virus dominant CD4 T cell epitopes and uses thereof
#565Methods for diagnosis prognosis and methods of treatment
#566IN VITRO ASSAY FOR IDENTIFICATION OF ALLERGENIC PROTEINS
#567Method of identifying improved conjugates of biologically active compounds
#568123 Human Secreted Proteins
#569Method for Monitoring the Immune Response and Predicting Clinical Outcomes in transplant recipients
#570Methods and compositions for risk stratification
#571Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6
#572Screening platform for discovery of immunomodulatory activities in traditional medicine
#573METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#574Process for the measurement of the potency of glatiramer acetate
#575MODULATION OF IMMUNE SYSTEM FUNCTION BY MODULATION OF POLYPEPTIDE ARGININE METHYLTRANSFERASES
#576Method of analyzing lymphocytes
#577Chemokine receptor antagonists as therapeutic agents
#578Method for screening therapeutic agent for glomerular disorder
#579Method to Determine Pseudo-Allergic Reactions
#580Methods For Determining Presence of Cancer by Analyzing the Expression of Cdk9 and/or Cyclin T1 in Lymphoid Tissue
#581Methods for suppressing activity of activated interferon-producing cells
#582Formulation of Multivalent Antibody Constructs and Use of Same for Cancer Therapy
#583Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
#584Assay Method
#585Diagnosis and Treatment of Siglec-6 Associated Diseases
#586MODULATION OF CD200 RECEPTORS
#587Peptides capable of binding to serum proteins
#588Modulation of Nkg2d
#589METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#590Methods of Screening Compounds to Predict Toxicity and Residual Proliferative and Differentiation Capacity of the Lympho-Hematopoietic System
#591GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
#592Population Based Prediction Methods for Immune Response Determinations and Methods for Verifying Immunological Response Data
#593Bone Marrow Proliferation Assay
#594ILCS based pattern recognition of sepsis
#595Anti-CD63 antibodies and methods of use thereof
#596Methods and compositions for risk stratification
#597Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#598Methods of suppressing microglial activation
#599Method for determining an allergic response
#600PEGYLATION OF THERAPEUTIC AGENTS